Component portfolio and prices

On this page:

 

Component portfolio

Portfolio of blood components and guidance for their clinical use (PDF 1MB)

This provides details of therapeutic blood components including constituents, and information on:

      • specifications
      • identification barcodes
      • quality standards and monitoring
      • storage and handling
      • clinical indications and contraindications
      • specialist requirements
      • dosage, administration, recognition of adverse effects
      • material safety data sheet

 

Apheresis platelets in PAS and plasma

Clinical issue of this component starts 12 January 2026, alongside the current apheresis platelets in plasma. You may receive either component after 12 January. Use the identification barcodes (PDF 29KB) to update LIMS.

Please refer to our FAQs (PDF 484KB) for more information. If you have any questions email michelle.ray@nhsbt.nhs.uk. Michelle is the Projects and Operational Support Lead in the Technical and Scientific Development team. 

 

Component and transport prices



Non stock and special components, including components for urgent requests

It is important you allow for processing and transport time when ordering these components. Please refer to Appendix 7 in the portfolio of blood components (download the PDF file of the portfolio using the link at the top of this page).